Carbapenem antibiotic
Pregnancy: Use only if clearly indicated. Limited data but may be used for serious infections.
Meropenem
Brand names: Meronem
Adult dose
Dose: 500 mg–2 g every 8 hours IV
Route: IV (bolus over 5 min or infusion over 15–30 min)
Frequency: Every 8 hours (or every 6 hours for CNS infections)
Max: 6 g/day (standard); 8 g/day (CNS/extended infusion)
Moderate infections: 500 mg every 8 hours. Severe/ICU: 1 g every 8 hours. CNS infections (meningitis): 2 g every 8 hours. Extended infusion (3 hours) for MDR organisms in critical care. Duration guided by clinical response and microbiological results.
Paediatric dose
Dose: 20 mg/kg
Route: IV
Frequency: Every 8 hours
Max: 2 g/dose
Concentration: 50 mg/ml
3 months–11 years: 10–20 mg/kg every 8 hours. Meningitis: 40 mg/kg every 8 hours (max 2 g). ≥12 years: adult dose. Neonates <7 days: 20 mg/kg every 12 hours.
Dose adjustments
Renal
eGFR 25–50: 1 g every 12h; eGFR 10–25: 500 mg every 12h; eGFR <10: 500 mg every 24h.
Hepatic
No dose adjustment required.
Paediatric weight-based calculator
3 months–11 years: 10–20 mg/kg every 8 hours. Meningitis: 40 mg/kg every 8 hours (max 2 g). ≥12 years: adult dose. Neonates <7 days: 20 mg/kg every 12 hours.
Clinical pearls
- Critically avoid combination with valproate — meropenem can halve valproate levels within 24 hours
- Broadest spectrum beta-lactam for Gram-negative organisms including Pseudomonas and ESBL producers
- Reserve for ESBL-producing Enterobacteriaceae, Pseudomonas, and polymicrobial severe infections
- Carbapenem stewardship essential — preserve for resistant organisms
- Less seizure-prone than imipenem-cilastatin
Contraindications
- Hypersensitivity to carbapenems
- Caution in penicillin allergy (1–5% cross-reactivity)
Side effects
- Diarrhoea
- Nausea and vomiting
- Elevated liver enzymes
- Thrombocytopenia
- Seizures (lower seizure threshold than imipenem)
- Hypersensitivity reactions
- C. difficile colitis
Interactions
- Sodium valproate — significantly reduces valproate levels (avoid combination)
- Probenecid — increases meropenem levels (avoid)
Monitoring
- U&E
- LFTs
- Microbiological response
- Valproate levels if on valproate
- Seizure risk
Reference: BNFc; BNF; PHE Antimicrobial Stewardship Guidelines; NICE NG51. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections
- Gustilo-Anderson Classification (Open Fractures) · Fracture Classification
- DRIP Score for Drug-Resistant Pneumonia · Pneumonia
Drugs
Pathways
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023